Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Enovis Corporation

Market Cap 126.47Cr 109.75Cr 101.16Cr 95Cr 177.11Cr 12TCr 180.79Cr 1.21TCr 467.21Cr 5.84TCr 474.75Cr 464.52Cr 20TCr P/E Ratio 2026 *
181x
P/E Ratio 2027 * 22.8x
Enterprise Value 247.32Cr 214.63Cr 197.84Cr 185.38Cr 346.36Cr 24TCr 353.57Cr 2.36TCr 913.71Cr 11TCr 928.45Cr 908.44Cr 40TCr EV / Sales 2026 *
1.05x
EV / Sales 2027 * 0.95x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-2.96%
1 week-6.93%
Current month-6.19%
1 month-14.14%
3 months-14.35%
6 months-23.53%
Current year-20.14%
1 week 20.55
Extreme 20.55
24.58
1 month 20.55
Extreme 20.55
26.66
Current year 20.55
Extreme 20.55
29.89
1 year 20.55
Extreme 20.55
36.82
3 years 20.55
Extreme 20.55
66.14
5 years 20.55
Extreme 20.55
164.01
10 years 20.55
Extreme 20.55
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Administrative Officer - 05/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
01/06Buy

Chief Administrative Officer

1,000 0.0017%
19/05Free

Director

9,346 0.0164%
19/05Free

Director

9,346 0.0164%
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%-6.93%-36.19%-63.25% 126.47Cr
-0.73%+1.95%-19.42%+9.70% 12TCr
-2.07%+0.35%+1.43%-4.09% 1.32TCr
+3.04%+3.46%+26.98%+88.11% 719.09Cr
-0.74%-8.35%-46.23%-69.62% 414.78Cr
-0.82%+2.89%+8.40%+30.33% 251.23Cr
+2.98%+3.73%-21.66%-19.19% 165.19Cr
-0.70%-10.77%+1.63%-12.89% 164.2Cr
-0.56%+1.31% - - 136.36Cr
Average -0.26%+1.51%-10.63%-5.11% 1.68TCr
Weighted average by Cap. -0.57%+4.31%-15.57%+9.22%

Financials

2026 *2027 *
Net sales 234.62Cr 203.6Cr 187.67Cr 175.85Cr 328.56Cr 22TCr 335.41Cr 2.24TCr 866.77Cr 11TCr 880.75Cr 861.77Cr 38TCr 246.98Cr 214.33Cr 197.57Cr 185.12Cr 345.88Cr 24TCr 353.09Cr 2.36TCr 912.45Cr 11TCr 927.17Cr 907.19Cr 40TCr
Net income 29.6L 25.69L 23.68L 22.19L 41.45L 28Cr 42.32L 2.82Cr 1.09Cr 14Cr 1.11Cr 1.09Cr 48Cr 5.42Cr 4.71Cr 4.34Cr 4.06Cr 7.59Cr 519.16Cr 7.75Cr 52Cr 20Cr 250.25Cr 20Cr 20Cr 870.13Cr
Net Debt 120.86Cr 104.88Cr 97Cr 91Cr 169.25Cr 12TCr 172.78Cr 1.15TCr 446.5Cr 5.58TCr 453.7Cr 443.92Cr 19TCr 108.34Cr 94Cr 87Cr 81Cr 151.73Cr 10TCr 154.89Cr 1.03TCr 400.26Cr 5TCr 406.72Cr 397.95Cr 17TCr
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
12/26/12 21.28 $ -3.14% 8,37,495
10/26/10 21.97 $ -8.31% 15,14,967
09/26/09 23.96 $ +1.18% 9,79,245
08/26/08 23.68 $ -0.42% 6,94,147
05/26/05 23.78 $ +4.02% 7,09,587
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.97USD
Average target price
43.00USD
Spread / Average Target
+95.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!